9989 — Sundrug Co Cashflow Statement
0.000.00%
- ¥511bn
- ¥485bn
- ¥802bn
- 96
- 51
- 82
- 91
Annual cashflow statement for Sundrug Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
Standards: | JAS | JAS | JAS | JAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 37,188 | 34,675 | 37,710 | 41,261 | 43,569 |
Depreciation | |||||
Non-Cash Items | 486 | -3,866 | 334 | 215 | 2,031 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -14,577 | -9,337 | -12,732 | -15,413 | -21,652 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 31,760 | 31,681 | 37,380 | 41,190 | 41,230 |
Capital Expenditures | -16,475 | -19,789 | -26,113 | -38,225 | -34,266 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -1,426 | -870 | -2,399 | -36,625 | -1,107 |
Acquisition of Business | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -17,901 | -20,659 | -28,512 | -74,850 | -35,373 |
Financing Cash Flow Items | — | — | -2 | -2 | -1 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -8,064 | -8,187 | -17,326 | 22,487 | -10,600 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 5,795 | 2,835 | -8,458 | -11,173 | -4,743 |